News / 10 Jan 2019
Completion of $25 million Subscription
News / 04 Jan 2019
Result of General Meeting
News / 17 Dec 2018
Proposed Subscription to Raise $25.0 million and Notice of General Meeting
We are building a very different antibiotics company that focuses on bringing innovation to antibiotic development. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.
Chief Executive Officer